East London experience with enteric fever 2007-2012

PloS One
Jayshree DaveArmine Sefton

Abstract

The clinical presentation and epidemiology for patients with enteric fever at two hospitals in East London during 2007-2012 is described with the aim to identify preventive opportunities and to reduce the cost of treatment. A retrospective analysis of case notes from patients admitted with enteric fever during 2007 to 2012 with a microbiologically confirmed diagnosis was undertaken. Details on clinical presentation, travel history, demographic data, laboratory parameters, treatment, patient outcome and vaccination status were collected. Clinical case notes were available for 98/129 (76%) patients including 69 Salmonella enterica serovar Typhi (S. Typhi) and 29 Salmonella enterica serovar Paratyphi (S. Paratyphi). Thirty-four patients (35%) were discharged from emergency medicine without a diagnosis of enteric fever and then readmitted after positive blood cultures. Seventy-one of the 98 patients (72%) were UK residents who had travelled abroad, 23 (23%) were foreign visitors/new entrants to the UK and four (4%) had not travelled abroad. Enteric fever was not considered in the initial differential diagnosis for 48/98 (49%) cases. The median length of hospital stay was 7 days (range 0-57 days). The total cost of bed days for mana...Continue Reading

References

Nov 29, 2002·The New England Journal of Medicine·Christopher M ParryJeremy J Farrar
Nov 1, 2005·Journal of Travel Medicine·Eyal MeltzerEli Schwartz
Apr 6, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ashish P MaskeyBuddha Basnyat
Feb 13, 2007·Travel Medicine and Infectious Disease·Fiona J Cooke, John Wain
Apr 29, 2008·Bulletin of the World Health Organization·R Leon OchiaiUNKNOWN Domi Typhoid Study Group
Dec 18, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John A Crump, Eric D Mintz
Mar 20, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Aliya NaheedRobert F Breiman
Jun 4, 2011·Travel Medicine and Infectious Disease·Srinivasulu ReddyArmine Sefton
May 29, 2012·The Journal of Infection·S BalasegaramUNKNOWN Typhoid and Paratyphoid Reference Group, Health Protection Agency, London, England
Aug 14, 2013·BMC Research Notes·Freja Cecille BarrettIsik Somuncu Johansen
Oct 15, 2013·The Journal of Infection·Claire S WaddingtonAndrew J Pollard

❮ Previous
Next ❯

Citations

Jun 8, 2017·Journal of Medical Microbiology·Jayshree DaveSooria Balasegaram
Mar 27, 2015·International Health·Jayshree Dave, Armine Sefton
Jul 31, 2018·Journal of Travel Medicine·Virginie PommeletAlbert Faye
Oct 31, 2017·International Journal of Microbiology·Rucha PatkiDhaneshwar Lanjewar
Oct 24, 2017·Current Opinion in Gastroenterology·Abhilasha KarkeyStephen Baker
Feb 8, 2021·Journal of Travel Medicine·Abi ManeshPriscilla Rupali
Oct 8, 2021·Journal of Travel Medicine·Dr Daniel P Forster, Professor Karin Leder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
S HumeJ Torresi
Nihon rinsho. Japanese journal of clinical medicine
Kenji Ohnishi
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
D T Fisk, S F Bradley
© 2021 Meta ULC. All rights reserved